Background: The first silicone breast implant was inserted in 1962. In 1997, the first case of
anaplastic large cell lymphoma (ALCL) in association with a silicone breast implant was …

Breast implant-associated anaplastic large cell lymphoma is a newly recognized provisional
entity in the 2017 revision of the World Health Organization Classification of Tumors of …

Background: A recent association between breast implants and the development of
anaplastic large-cell lymphoma (ALCL) has been observed. The purpose of this study was to …

Purpose Breast implant–associated anaplastic large-cell lymphoma (ALCL) is a recently
described clinicopathologic entity that usually presents as an effusion-associated fibrous …

Almost 200 women worldwide have been diagnosed with breast implant-associated
anaplastic large cell lymphoma (BIA-ALCL). The unique location and specific lymphoma …

Breast implant-associated anaplastic large cell lymphoma (BIA ALCL) is a newly described
clinicopathologic entity. The purpose of this study is to describe the imaging findings of …

The risk of hematological malignancies is mainly determined by genetic background, age,
sex, race and ethnicity, geographic location, exposure to certain chemicals and radiation; …

Anaplastic large cell lymphomas (ALCLs) represent a group of CD30-positive T-cell non-
Hodgkin lymphomas with unifying morphological characteristics but variable clinical and …

Systemic anaplastic large cell lymphoma (sALCL) is an aggressive T-cell non Hodgkin
lymphoma which is divided into two categories based on the expression of the anaplastic …

Silicone breast implants are commonly used for cosmetic and oncologic surgical indications
owing to their inertness and being nontoxic. However, complications including capsular …